http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015019811-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D245-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
filingDate 2014-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900cbc29a846e29bec3b89d9e01f0dce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a27ab9cdccfc273a1c004a5d50c6382b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f51d2554a1c7ddbc3de25f353c73db31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d4d1f197c9c58d8488d50cda43dbe30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c15e768f736b57c70f8413a12f46880
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c76fcb5aea157e8a1712f1a286e7d1e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eb755534eb6ed7886fc40c78502be90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e469dfebd37c7dbcca2ede101fe13fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_472349cd3d195f3b544ff160bb750b40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c1442dad05d3e0373802a06db169317
publicationDate 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112015019811-A2
titleOfInvention Bicyclic 2,3-benzodiazepines and substituted spirocyclic 2,3-benzodiazepines
abstract Summary Bicyclic 2,3-benzodiazepines and substituted spirocyclic 2,3-benzodiazepines. inhibitory bet protein, in particular inhibitory brd4, substituted bicyclic and spirocyclic 2,3-benzodiazepines of the general formula (i), pharmaceutical compositions consisting of the compounds according to the invention, and their prophylactic and therapeutic use for hyperproliferative diseases, are described, especially tumoral diseases. In addition, the use of bet protein inhibitors in benign hyperplasia, atherosclerotic disease, sepsis, autoimmune disease, vascular disease, viral infection, neurodegenerative disease, inflammatory disease, atherosclerotic disease, and male fertility control is also described. 1/1
priorityDate 2013-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22015773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420625825

Total number of triples: 66.